D-Dimer Testing Market by Testing Methods (Clinical Chemistry Analyzers, Coagulation Analyzers, Laboratory Testing, Point-of-Care Testing), and Applications (Deep Vein Thrombosis, Disseminated Intravascular Coagulation, Pulmonary Embolism) and Forecast 2017-2021

D-Dimer Testing Market by Testing Methods (Clinical Chemistry Analyzers, Coagulation Analyzers, Laboratory Testing, Point-of-Care Testing), and Applications (Deep Vein Thrombosis, Disseminated Intravascular Coagulation, Pulmonary Embolism) and Forecast 2017-2021

D-dimer is a fibrin degradation product (or FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. D-dimer concentration may be determined by a blood test to help diagnose thrombosis in patients with suspected thrombotic disorders. D-dimer test was preferred as an initial test to diagnose thrombosis and rule out DVT in order to reduce the number of patients seeking alternative diagnostic therapy. Non-invasiveness and lack of radiologist intervention are the prominent drivers of quantification of D-dimer levels in deep vein thrombosis detection. It is mostly used to exclude thromboembolic disease and to diagnose blood disorder disseminated intravascular coagulation.

The global D-dimer testing market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global D-dimer testing market segmentation is based on testing methods (Clinical Chemistry Analyzers, Coagulation Analyzers, Laboratory Testing, Point-of-care Testing), and its applications (Deep Vein Thrombosis (DVT), Disseminated Intravascular Coagulation (DIC), and Pulmonary Embolism (PE).

The global D-dimer testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global D-dimer testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global D-dimer testing market and included in this report are Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., Bio/Data Corporation, Becton, Dickinson and Company, Corgenix, F. Hoffman-La Roche Ltd., Helena Biosciences, Siemens Healthcare, Sysmex Corporation, Trinity Biotech, and Thermo Fisher Scientific.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

D-Dimer Testing Market

1. Testing Method
1.1. Clinical Chemistry Analyzers
1.2. Coagulation Analyzers
1.3. Laboratory Testing
1.4. Point-of-care Testing

2. Application
2.1. Deep Vein Thrombosis (DVT)
2.2. Disseminated Intravascular Coagulation (DIC)
2.3. Pulmonary Embolism (PE)

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories, Inc.
4.2. Alere, Inc.
4.3. Beckman Coulter, Inc.
4.4. Bio/Data Corporation
4.5. Becton, Dickinson and Company
4.6. Corgenix Medical Corporation
4.7. F. Hoffmann-La Roche Ltd.
4.8. Helena Biosciences
4.9. Sysmex Corporation
4.10. Siemens Healthcare
4.11. Thermo Fisher Scientific, Inc.
4.12. Trinity Biotech plc

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*